nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2D6—Hydroxyurea—head and neck cancer	0.125	0.308	CbGbCtD
Mirtazapine—CYP2C8—Fluorouracil—head and neck cancer	0.0749	0.185	CbGbCtD
Mirtazapine—CYP1A2—Fluorouracil—head and neck cancer	0.058	0.143	CbGbCtD
Mirtazapine—CYP2C9—Fluorouracil—head and neck cancer	0.0522	0.129	CbGbCtD
Mirtazapine—CYP2D6—Vinblastine—head and neck cancer	0.0442	0.109	CbGbCtD
Mirtazapine—CYP3A4—Vinblastine—head and neck cancer	0.0281	0.0694	CbGbCtD
Mirtazapine—CYP3A4—Docetaxel—head and neck cancer	0.0232	0.0572	CbGbCtD
Mirtazapine—HTR7—superior cervical ganglion—head and neck cancer	0.0137	0.167	CbGeAlD
Mirtazapine—HTR3A—cranial nerve—head and neck cancer	0.00854	0.104	CbGeAlD
Mirtazapine—HRH1—nose—head and neck cancer	0.00737	0.0895	CbGeAlD
Mirtazapine—HTR7—cranial nerve—head and neck cancer	0.00552	0.067	CbGeAlD
Mirtazapine—HTR2A—trigeminal nerve—head and neck cancer	0.00483	0.0587	CbGeAlD
Mirtazapine—HTR2A—cranial nerve—head and neck cancer	0.00344	0.0418	CbGeAlD
Mirtazapine—Ulcer—Fluorouracil—head and neck cancer	0.00253	0.00687	CcSEcCtD
Mirtazapine—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00252	0.00686	CcSEcCtD
Mirtazapine—Throat sore—Docetaxel—head and neck cancer	0.0024	0.00651	CcSEcCtD
Mirtazapine—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00237	0.00645	CcSEcCtD
Mirtazapine—Face oedema—Hydroxyurea—head and neck cancer	0.00233	0.00633	CcSEcCtD
Mirtazapine—Angina pectoris—Vinblastine—head and neck cancer	0.00223	0.00605	CcSEcCtD
Mirtazapine—Otitis media—Docetaxel—head and neck cancer	0.00222	0.00603	CcSEcCtD
Mirtazapine—Coma—Fluorouracil—head and neck cancer	0.00219	0.00594	CcSEcCtD
Mirtazapine—Pancytopenia—Vinblastine—head and neck cancer	0.00217	0.0059	CcSEcCtD
Mirtazapine—HRH3—head—head and neck cancer	0.00216	0.0263	CbGeAlD
Mirtazapine—Ageusia—Docetaxel—head and neck cancer	0.00213	0.00579	CcSEcCtD
Mirtazapine—Euphoric mood—Fluorouracil—head and neck cancer	0.00206	0.00558	CcSEcCtD
Mirtazapine—Pancreatitis—Hydroxyurea—head and neck cancer	0.00204	0.00555	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00201	0.00546	CcSEcCtD
Mirtazapine—Myocardial infarction—Vinblastine—head and neck cancer	0.002	0.00543	CcSEcCtD
Mirtazapine—Pancytopenia—Hydroxyurea—head and neck cancer	0.00198	0.00538	CcSEcCtD
Mirtazapine—Amenorrhoea—Docetaxel—head and neck cancer	0.00197	0.00534	CcSEcCtD
Mirtazapine—Neutropenia—Hydroxyurea—head and neck cancer	0.00195	0.0053	CcSEcCtD
Mirtazapine—Dysuria—Hydroxyurea—head and neck cancer	0.00195	0.0053	CcSEcCtD
Mirtazapine—Disorientation—Fluorouracil—head and neck cancer	0.00194	0.00527	CcSEcCtD
Mirtazapine—Bone disorder—Docetaxel—head and neck cancer	0.00191	0.00519	CcSEcCtD
Mirtazapine—Agranulocytosis—Vinblastine—head and neck cancer	0.0019	0.00517	CcSEcCtD
Mirtazapine—Oropharyngeal pain—Docetaxel—head and neck cancer	0.0019	0.00516	CcSEcCtD
Mirtazapine—Weight increased—Hydroxyurea—head and neck cancer	0.0019	0.00516	CcSEcCtD
Mirtazapine—HTR7—mouth—head and neck cancer	0.00186	0.0226	CbGeAlD
Mirtazapine—Drowsiness—Hydroxyurea—head and neck cancer	0.00186	0.00505	CcSEcCtD
Mirtazapine—Amnesia—Fluorouracil—head and neck cancer	0.00185	0.00502	CcSEcCtD
Mirtazapine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00182	0.00495	CcSEcCtD
Mirtazapine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00182	0.00494	CcSEcCtD
Mirtazapine—Pharyngitis—Vinblastine—head and neck cancer	0.00182	0.00494	CcSEcCtD
Mirtazapine—Stomatitis—Hydroxyurea—head and neck cancer	0.00181	0.00492	CcSEcCtD
Mirtazapine—Bone pain—Docetaxel—head and neck cancer	0.0018	0.0049	CcSEcCtD
Mirtazapine—Lethargy—Fluorouracil—head and neck cancer	0.00177	0.00482	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00176	0.00478	CcSEcCtD
Mirtazapine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00174	0.00472	CcSEcCtD
Mirtazapine—Pulmonary embolism—Docetaxel—head and neck cancer	0.00173	0.00469	CcSEcCtD
Mirtazapine—Hallucination—Hydroxyurea—head and neck cancer	0.00166	0.00451	CcSEcCtD
Mirtazapine—Colitis—Docetaxel—head and neck cancer	0.00166	0.0045	CcSEcCtD
Mirtazapine—Candida infection—Docetaxel—head and neck cancer	0.00165	0.00448	CcSEcCtD
Mirtazapine—Fluid retention—Docetaxel—head and neck cancer	0.00164	0.00445	CcSEcCtD
Mirtazapine—Ataxia—Fluorouracil—head and neck cancer	0.00163	0.00444	CcSEcCtD
Mirtazapine—Alopecia—Vinblastine—head and neck cancer	0.00162	0.00439	CcSEcCtD
Mirtazapine—Dry skin—Fluorouracil—head and neck cancer	0.00159	0.00433	CcSEcCtD
Mirtazapine—HTR7—neck—head and neck cancer	0.00159	0.0193	CbGeAlD
Mirtazapine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00154	0.00418	CcSEcCtD
Mirtazapine—Muscular weakness—Fluorouracil—head and neck cancer	0.00153	0.00416	CcSEcCtD
Mirtazapine—Angiopathy—Hydroxyurea—head and neck cancer	0.00151	0.00411	CcSEcCtD
Mirtazapine—DRD3—head—head and neck cancer	0.0015	0.0182	CbGeAlD
Mirtazapine—Chills—Hydroxyurea—head and neck cancer	0.0015	0.00407	CcSEcCtD
Mirtazapine—Eosinophilia—Fluorouracil—head and neck cancer	0.00149	0.00404	CcSEcCtD
Mirtazapine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00148	0.00402	CcSEcCtD
Mirtazapine—Alopecia—Hydroxyurea—head and neck cancer	0.00148	0.00401	CcSEcCtD
Mirtazapine—Anaemia—Vinblastine—head and neck cancer	0.00147	0.004	CcSEcCtD
Mirtazapine—Angina pectoris—Fluorouracil—head and neck cancer	0.00146	0.00397	CcSEcCtD
Mirtazapine—Phlebitis—Docetaxel—head and neck cancer	0.00146	0.00395	CcSEcCtD
Mirtazapine—Malaise—Vinblastine—head and neck cancer	0.00144	0.0039	CcSEcCtD
Mirtazapine—Vertigo—Vinblastine—head and neck cancer	0.00143	0.00389	CcSEcCtD
Mirtazapine—Leukopenia—Vinblastine—head and neck cancer	0.00143	0.00387	CcSEcCtD
Mirtazapine—Pancytopenia—Fluorouracil—head and neck cancer	0.00143	0.00387	CcSEcCtD
Mirtazapine—Deafness—Docetaxel—head and neck cancer	0.0014	0.00381	CcSEcCtD
Mirtazapine—ADRB1—connective tissue—head and neck cancer	0.00139	0.0169	CbGeAlD
Mirtazapine—Convulsion—Vinblastine—head and neck cancer	0.00138	0.00375	CcSEcCtD
Mirtazapine—Hypertension—Vinblastine—head and neck cancer	0.00138	0.00374	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00137	0.00372	CcSEcCtD
Mirtazapine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00135	0.00366	CcSEcCtD
Mirtazapine—Pneumonia—Fluorouracil—head and neck cancer	0.00135	0.00366	CcSEcCtD
Mirtazapine—Anaemia—Hydroxyurea—head and neck cancer	0.00134	0.00365	CcSEcCtD
Mirtazapine—Discomfort—Vinblastine—head and neck cancer	0.00134	0.00364	CcSEcCtD
Mirtazapine—OPRK1—head—head and neck cancer	0.00134	0.0162	CbGeAlD
Mirtazapine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00132	0.00358	CcSEcCtD
Mirtazapine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00131	0.00356	CcSEcCtD
Mirtazapine—Dermatitis bullous—Docetaxel—head and neck cancer	0.00131	0.00356	CcSEcCtD
Mirtazapine—Malaise—Hydroxyurea—head and neck cancer	0.00131	0.00356	CcSEcCtD
Mirtazapine—Stomatitis—Fluorouracil—head and neck cancer	0.0013	0.00354	CcSEcCtD
Mirtazapine—Conjunctivitis—Fluorouracil—head and neck cancer	0.0013	0.00353	CcSEcCtD
Mirtazapine—Urinary tract infection—Fluorouracil—head and neck cancer	0.0013	0.00353	CcSEcCtD
Mirtazapine—Leukopenia—Hydroxyurea—head and neck cancer	0.0013	0.00353	CcSEcCtD
Mirtazapine—Lethargy—Docetaxel—head and neck cancer	0.00128	0.00348	CcSEcCtD
Mirtazapine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00127	0.00346	CcSEcCtD
Mirtazapine—Epistaxis—Fluorouracil—head and neck cancer	0.00126	0.00343	CcSEcCtD
Mirtazapine—Convulsion—Hydroxyurea—head and neck cancer	0.00126	0.00342	CcSEcCtD
Mirtazapine—Hyponatraemia—Docetaxel—head and neck cancer	0.00126	0.00342	CcSEcCtD
Mirtazapine—Sinusitis—Fluorouracil—head and neck cancer	0.00126	0.00341	CcSEcCtD
Mirtazapine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00125	0.00339	CcSEcCtD
Mirtazapine—Anorexia—Vinblastine—head and neck cancer	0.00124	0.00337	CcSEcCtD
Mirtazapine—Migraine—Docetaxel—head and neck cancer	0.00123	0.00335	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00123	0.00334	CcSEcCtD
Mirtazapine—Discomfort—Hydroxyurea—head and neck cancer	0.00122	0.00332	CcSEcCtD
Mirtazapine—Rhinitis—Fluorouracil—head and neck cancer	0.0012	0.00327	CcSEcCtD
Mirtazapine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0012	0.00325	CcSEcCtD
Mirtazapine—Pharyngitis—Fluorouracil—head and neck cancer	0.00119	0.00324	CcSEcCtD
Mirtazapine—ADRA2C—parotid gland—head and neck cancer	0.00119	0.0144	CbGeAlD
Mirtazapine—Oedema—Hydroxyurea—head and neck cancer	0.00119	0.00322	CcSEcCtD
Mirtazapine—Ataxia—Docetaxel—head and neck cancer	0.00118	0.0032	CcSEcCtD
Mirtazapine—Infection—Hydroxyurea—head and neck cancer	0.00118	0.0032	CcSEcCtD
Mirtazapine—Paraesthesia—Vinblastine—head and neck cancer	0.00117	0.00317	CcSEcCtD
Mirtazapine—Dehydration—Docetaxel—head and neck cancer	0.00117	0.00317	CcSEcCtD
Mirtazapine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00116	0.00316	CcSEcCtD
Mirtazapine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00116	0.00315	CcSEcCtD
Mirtazapine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00116	0.00314	CcSEcCtD
Mirtazapine—Skin disorder—Hydroxyurea—head and neck cancer	0.00115	0.00313	CcSEcCtD
Mirtazapine—Dry skin—Docetaxel—head and neck cancer	0.00115	0.00312	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00114	0.00311	CcSEcCtD
Mirtazapine—HTR7—connective tissue—head and neck cancer	0.00114	0.0138	CbGeAlD
Mirtazapine—Anorexia—Hydroxyurea—head and neck cancer	0.00113	0.00307	CcSEcCtD
Mirtazapine—Decreased appetite—Vinblastine—head and neck cancer	0.00113	0.00307	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00113	0.00307	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00113	0.00307	CcSEcCtD
Mirtazapine—Pain—Vinblastine—head and neck cancer	0.00111	0.00302	CcSEcCtD
Mirtazapine—Constipation—Vinblastine—head and neck cancer	0.00111	0.00302	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00111	0.003	CcSEcCtD
Mirtazapine—HTR7—epithelium—head and neck cancer	0.00108	0.0131	CbGeAlD
Mirtazapine—Arrhythmia—Fluorouracil—head and neck cancer	0.00107	0.00292	CcSEcCtD
Mirtazapine—Feeling abnormal—Vinblastine—head and neck cancer	0.00107	0.00291	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00106	0.00289	CcSEcCtD
Mirtazapine—Alopecia—Fluorouracil—head and neck cancer	0.00106	0.00288	CcSEcCtD
Mirtazapine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00106	0.00287	CcSEcCtD
Mirtazapine—Angina pectoris—Docetaxel—head and neck cancer	0.00106	0.00287	CcSEcCtD
Mirtazapine—Somnolence—Hydroxyurea—head and neck cancer	0.00105	0.00286	CcSEcCtD
Mirtazapine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00104	0.00284	CcSEcCtD
Mirtazapine—ADRA1A—epithelium—head and neck cancer	0.00104	0.0127	CbGeAlD
Mirtazapine—HTR3A—head—head and neck cancer	0.00104	0.0126	CbGeAlD
Mirtazapine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00103	0.0028	CcSEcCtD
Mirtazapine—Pancytopenia—Docetaxel—head and neck cancer	0.00103	0.0028	CcSEcCtD
Mirtazapine—Abdominal pain—Vinblastine—head and neck cancer	0.00103	0.00279	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00102	0.00278	CcSEcCtD
Mirtazapine—Fatigue—Hydroxyurea—head and neck cancer	0.00102	0.00278	CcSEcCtD
Mirtazapine—Pain—Hydroxyurea—head and neck cancer	0.00101	0.00276	CcSEcCtD
Mirtazapine—Constipation—Hydroxyurea—head and neck cancer	0.00101	0.00276	CcSEcCtD
Mirtazapine—Neutropenia—Docetaxel—head and neck cancer	0.00101	0.00275	CcSEcCtD
Mirtazapine—HTR2A—neck—head and neck cancer	0.000992	0.012	CbGeAlD
Mirtazapine—Weight increased—Docetaxel—head and neck cancer	0.000986	0.00268	CcSEcCtD
Mirtazapine—Weight decreased—Docetaxel—head and neck cancer	0.00098	0.00266	CcSEcCtD
Mirtazapine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000977	0.00266	CcSEcCtD
Mirtazapine—Pneumonia—Docetaxel—head and neck cancer	0.000972	0.00264	CcSEcCtD
Mirtazapine—Anaemia—Fluorouracil—head and neck cancer	0.000967	0.00263	CcSEcCtD
Mirtazapine—Hypersensitivity—Vinblastine—head and neck cancer	0.000958	0.0026	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000958	0.0026	CcSEcCtD
Mirtazapine—HTR7—trachea—head and neck cancer	0.000957	0.0116	CbGeAlD
Mirtazapine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000952	0.00259	CcSEcCtD
Mirtazapine—Myocardial infarction—Docetaxel—head and neck cancer	0.000947	0.00257	CcSEcCtD
Mirtazapine—Jaundice—Docetaxel—head and neck cancer	0.000942	0.00256	CcSEcCtD
Mirtazapine—Stomatitis—Docetaxel—head and neck cancer	0.000942	0.00256	CcSEcCtD
Mirtazapine—Conjunctivitis—Docetaxel—head and neck cancer	0.000939	0.00255	CcSEcCtD
Mirtazapine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000937	0.00255	CcSEcCtD
Mirtazapine—Leukopenia—Fluorouracil—head and neck cancer	0.000936	0.00254	CcSEcCtD
Mirtazapine—Asthenia—Vinblastine—head and neck cancer	0.000933	0.00253	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000914	0.00248	CcSEcCtD
Mirtazapine—Epistaxis—Docetaxel—head and neck cancer	0.000911	0.00248	CcSEcCtD
Mirtazapine—Convulsion—Fluorouracil—head and neck cancer	0.000906	0.00246	CcSEcCtD
Mirtazapine—Agranulocytosis—Docetaxel—head and neck cancer	0.000901	0.00245	CcSEcCtD
Mirtazapine—Chest pain—Fluorouracil—head and neck cancer	0.00089	0.00242	CcSEcCtD
Mirtazapine—Myalgia—Fluorouracil—head and neck cancer	0.00089	0.00242	CcSEcCtD
Mirtazapine—Diarrhoea—Vinblastine—head and neck cancer	0.00089	0.00242	CcSEcCtD
Mirtazapine—HTR2B—thyroid gland—head and neck cancer	0.000884	0.0107	CbGeAlD
Mirtazapine—Discomfort—Fluorouracil—head and neck cancer	0.00088	0.00239	CcSEcCtD
Mirtazapine—ADRA2C—trachea—head and neck cancer	0.000879	0.0107	CbGeAlD
Mirtazapine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000874	0.00237	CcSEcCtD
Mirtazapine—Rhinitis—Docetaxel—head and neck cancer	0.000869	0.00236	CcSEcCtD
Mirtazapine—Hepatitis—Docetaxel—head and neck cancer	0.000867	0.00236	CcSEcCtD
Mirtazapine—SLC6A3—head—head and neck cancer	0.000863	0.0105	CbGeAlD
Mirtazapine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000863	0.00234	CcSEcCtD
Mirtazapine—Confusional state—Fluorouracil—head and neck cancer	0.000861	0.00234	CcSEcCtD
Mirtazapine—Pharyngitis—Docetaxel—head and neck cancer	0.000861	0.00234	CcSEcCtD
Mirtazapine—Dizziness—Vinblastine—head and neck cancer	0.00086	0.00234	CcSEcCtD
Mirtazapine—Urinary tract disorder—Docetaxel—head and neck cancer	0.000856	0.00233	CcSEcCtD
Mirtazapine—Oedema peripheral—Docetaxel—head and neck cancer	0.000854	0.00232	CcSEcCtD
Mirtazapine—Oedema—Fluorouracil—head and neck cancer	0.000854	0.00232	CcSEcCtD
Mirtazapine—HRH1—connective tissue—head and neck cancer	0.000851	0.0103	CbGeAlD
Mirtazapine—Asthenia—Hydroxyurea—head and neck cancer	0.000851	0.00231	CcSEcCtD
Mirtazapine—Urethral disorder—Docetaxel—head and neck cancer	0.00085	0.00231	CcSEcCtD
Mirtazapine—Infection—Fluorouracil—head and neck cancer	0.000848	0.0023	CcSEcCtD
Mirtazapine—Nervous system disorder—Fluorouracil—head and neck cancer	0.000837	0.00227	CcSEcCtD
Mirtazapine—ADRA2A—connective tissue—head and neck cancer	0.000836	0.0101	CbGeAlD
Mirtazapine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000836	0.00227	CcSEcCtD
Mirtazapine—HTR2C—head—head and neck cancer	0.000835	0.0101	CbGeAlD
Mirtazapine—Tachycardia—Fluorouracil—head and neck cancer	0.000833	0.00226	CcSEcCtD
Mirtazapine—Vomiting—Vinblastine—head and neck cancer	0.000827	0.00225	CcSEcCtD
Mirtazapine—Erythema multiforme—Docetaxel—head and neck cancer	0.00082	0.00223	CcSEcCtD
Mirtazapine—ADRB1—head—head and neck cancer	0.000819	0.00994	CbGeAlD
Mirtazapine—Headache—Vinblastine—head and neck cancer	0.000815	0.00221	CcSEcCtD
Mirtazapine—Anorexia—Fluorouracil—head and neck cancer	0.000814	0.00221	CcSEcCtD
Mirtazapine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000811	0.0022	CcSEcCtD
Mirtazapine—Eye disorder—Docetaxel—head and neck cancer	0.00081	0.0022	CcSEcCtD
Mirtazapine—HRH1—epithelium—head and neck cancer	0.000808	0.00981	CbGeAlD
Mirtazapine—Cardiac disorder—Docetaxel—head and neck cancer	0.000805	0.00219	CcSEcCtD
Mirtazapine—ADRA1A—lymphoid tissue—head and neck cancer	0.000804	0.00976	CbGeAlD
Mirtazapine—Hypotension—Fluorouracil—head and neck cancer	0.000798	0.00217	CcSEcCtD
Mirtazapine—SLC6A4—head—head and neck cancer	0.000791	0.00961	CbGeAlD
Mirtazapine—Angiopathy—Docetaxel—head and neck cancer	0.000787	0.00214	CcSEcCtD
Mirtazapine—Dizziness—Hydroxyurea—head and neck cancer	0.000784	0.00213	CcSEcCtD
Mirtazapine—HTR2B—head—head and neck cancer	0.000784	0.00952	CbGeAlD
Mirtazapine—Chills—Docetaxel—head and neck cancer	0.000778	0.00211	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000778	0.00211	CcSEcCtD
Mirtazapine—Arrhythmia—Docetaxel—head and neck cancer	0.000775	0.0021	CcSEcCtD
Mirtazapine—Nausea—Vinblastine—head and neck cancer	0.000772	0.0021	CcSEcCtD
Mirtazapine—Insomnia—Fluorouracil—head and neck cancer	0.000772	0.0021	CcSEcCtD
Mirtazapine—Paraesthesia—Fluorouracil—head and neck cancer	0.000767	0.00208	CcSEcCtD
Mirtazapine—Alopecia—Docetaxel—head and neck cancer	0.000766	0.00208	CcSEcCtD
Mirtazapine—Dyspnoea—Fluorouracil—head and neck cancer	0.000761	0.00207	CcSEcCtD
Mirtazapine—Mental disorder—Docetaxel—head and neck cancer	0.00076	0.00206	CcSEcCtD
Mirtazapine—Somnolence—Fluorouracil—head and neck cancer	0.000759	0.00206	CcSEcCtD
Mirtazapine—Malnutrition—Docetaxel—head and neck cancer	0.000755	0.00205	CcSEcCtD
Mirtazapine—Vomiting—Hydroxyurea—head and neck cancer	0.000754	0.00205	CcSEcCtD
Mirtazapine—Dyspepsia—Fluorouracil—head and neck cancer	0.000751	0.00204	CcSEcCtD
Mirtazapine—Rash—Hydroxyurea—head and neck cancer	0.000748	0.00203	CcSEcCtD
Mirtazapine—Dermatitis—Hydroxyurea—head and neck cancer	0.000747	0.00203	CcSEcCtD
Mirtazapine—Headache—Hydroxyurea—head and neck cancer	0.000743	0.00202	CcSEcCtD
Mirtazapine—Decreased appetite—Fluorouracil—head and neck cancer	0.000742	0.00202	CcSEcCtD
Mirtazapine—Dysgeusia—Docetaxel—head and neck cancer	0.000739	0.00201	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000737	0.002	CcSEcCtD
Mirtazapine—Back pain—Docetaxel—head and neck cancer	0.00073	0.00198	CcSEcCtD
Mirtazapine—Pain—Fluorouracil—head and neck cancer	0.00073	0.00198	CcSEcCtD
Mirtazapine—HRH1—trachea—head and neck cancer	0.000714	0.00867	CbGeAlD
Mirtazapine—HTR2A—connective tissue—head and neck cancer	0.000711	0.00863	CbGeAlD
Mirtazapine—Nausea—Hydroxyurea—head and neck cancer	0.000704	0.00191	CcSEcCtD
Mirtazapine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000703	0.00191	CcSEcCtD
Mirtazapine—HTR1A—head—head and neck cancer	0.000703	0.00853	CbGeAlD
Mirtazapine—ADRA2A—trachea—head and neck cancer	0.000702	0.00852	CbGeAlD
Mirtazapine—Anaemia—Docetaxel—head and neck cancer	0.000698	0.0019	CcSEcCtD
Mirtazapine—SLC6A2—head—head and neck cancer	0.000697	0.00846	CbGeAlD
Mirtazapine—Urticaria—Fluorouracil—head and neck cancer	0.000678	0.00184	CcSEcCtD
Mirtazapine—Syncope—Docetaxel—head and neck cancer	0.000677	0.00184	CcSEcCtD
Mirtazapine—Leukopenia—Docetaxel—head and neck cancer	0.000676	0.00184	CcSEcCtD
Mirtazapine—Body temperature increased—Fluorouracil—head and neck cancer	0.000675	0.00183	CcSEcCtD
Mirtazapine—HTR2A—epithelium—head and neck cancer	0.000675	0.00819	CbGeAlD
Mirtazapine—HTR7—head—head and neck cancer	0.000671	0.00815	CbGeAlD
Mirtazapine—Palpitations—Docetaxel—head and neck cancer	0.000667	0.00181	CcSEcCtD
Mirtazapine—Loss of consciousness—Docetaxel—head and neck cancer	0.000664	0.0018	CcSEcCtD
Mirtazapine—Cough—Docetaxel—head and neck cancer	0.000659	0.00179	CcSEcCtD
Mirtazapine—Convulsion—Docetaxel—head and neck cancer	0.000654	0.00178	CcSEcCtD
Mirtazapine—Hypertension—Docetaxel—head and neck cancer	0.000652	0.00177	CcSEcCtD
Mirtazapine—ADRA1A—head—head and neck cancer	0.000648	0.00786	CbGeAlD
Mirtazapine—Chest pain—Docetaxel—head and neck cancer	0.000643	0.00175	CcSEcCtD
Mirtazapine—Arthralgia—Docetaxel—head and neck cancer	0.000643	0.00175	CcSEcCtD
Mirtazapine—Myalgia—Docetaxel—head and neck cancer	0.000643	0.00175	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000638	0.00173	CcSEcCtD
Mirtazapine—DRD2—head—head and neck cancer	0.000635	0.00771	CbGeAlD
Mirtazapine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000629	0.00171	CcSEcCtD
Mirtazapine—Dry mouth—Docetaxel—head and neck cancer	0.000629	0.00171	CcSEcCtD
Mirtazapine—Confusional state—Docetaxel—head and neck cancer	0.000621	0.00169	CcSEcCtD
Mirtazapine—ADRA2C—head—head and neck cancer	0.000617	0.00749	CbGeAlD
Mirtazapine—Oedema—Docetaxel—head and neck cancer	0.000616	0.00167	CcSEcCtD
Mirtazapine—Infection—Docetaxel—head and neck cancer	0.000612	0.00166	CcSEcCtD
Mirtazapine—Shock—Docetaxel—head and neck cancer	0.000606	0.00165	CcSEcCtD
Mirtazapine—Nervous system disorder—Docetaxel—head and neck cancer	0.000604	0.00164	CcSEcCtD
Mirtazapine—Pruritus—Fluorouracil—head and neck cancer	0.000604	0.00164	CcSEcCtD
Mirtazapine—CYP1A2—thyroid gland—head and neck cancer	0.000604	0.00733	CbGeAlD
Mirtazapine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000603	0.00164	CcSEcCtD
Mirtazapine—Tachycardia—Docetaxel—head and neck cancer	0.000601	0.00163	CcSEcCtD
Mirtazapine—Skin disorder—Docetaxel—head and neck cancer	0.000598	0.00163	CcSEcCtD
Mirtazapine—HTR2A—trachea—head and neck cancer	0.000597	0.00724	CbGeAlD
Mirtazapine—Anorexia—Docetaxel—head and neck cancer	0.000587	0.0016	CcSEcCtD
Mirtazapine—Diarrhoea—Fluorouracil—head and neck cancer	0.000584	0.00159	CcSEcCtD
Mirtazapine—Hypotension—Docetaxel—head and neck cancer	0.000576	0.00156	CcSEcCtD
Mirtazapine—Dizziness—Fluorouracil—head and neck cancer	0.000564	0.00153	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000561	0.00153	CcSEcCtD
Mirtazapine—Insomnia—Docetaxel—head and neck cancer	0.000557	0.00151	CcSEcCtD
Mirtazapine—ADRA2A—thyroid gland—head and neck cancer	0.000555	0.00674	CbGeAlD
Mirtazapine—Paraesthesia—Docetaxel—head and neck cancer	0.000553	0.0015	CcSEcCtD
Mirtazapine—Dyspnoea—Docetaxel—head and neck cancer	0.000549	0.00149	CcSEcCtD
Mirtazapine—HTR2B—lymph node—head and neck cancer	0.000549	0.00667	CbGeAlD
Mirtazapine—Somnolence—Docetaxel—head and neck cancer	0.000548	0.00149	CcSEcCtD
Mirtazapine—Vomiting—Fluorouracil—head and neck cancer	0.000543	0.00147	CcSEcCtD
Mirtazapine—Dyspepsia—Docetaxel—head and neck cancer	0.000542	0.00147	CcSEcCtD
Mirtazapine—Rash—Fluorouracil—head and neck cancer	0.000538	0.00146	CcSEcCtD
Mirtazapine—Dermatitis—Fluorouracil—head and neck cancer	0.000538	0.00146	CcSEcCtD
Mirtazapine—Decreased appetite—Docetaxel—head and neck cancer	0.000536	0.00146	CcSEcCtD
Mirtazapine—Headache—Fluorouracil—head and neck cancer	0.000535	0.00145	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000532	0.00145	CcSEcCtD
Mirtazapine—Fatigue—Docetaxel—head and neck cancer	0.000531	0.00144	CcSEcCtD
Mirtazapine—Pain—Docetaxel—head and neck cancer	0.000527	0.00143	CcSEcCtD
Mirtazapine—Constipation—Docetaxel—head and neck cancer	0.000527	0.00143	CcSEcCtD
Mirtazapine—Feeling abnormal—Docetaxel—head and neck cancer	0.000508	0.00138	CcSEcCtD
Mirtazapine—Nausea—Fluorouracil—head and neck cancer	0.000507	0.00138	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000504	0.00137	CcSEcCtD
Mirtazapine—HRH1—head—head and neck cancer	0.000501	0.00609	CbGeAlD
Mirtazapine—ADRA2A—head—head and neck cancer	0.000492	0.00598	CbGeAlD
Mirtazapine—SLC6A2—lymph node—head and neck cancer	0.000488	0.00592	CbGeAlD
Mirtazapine—Abdominal pain—Docetaxel—head and neck cancer	0.000487	0.00132	CcSEcCtD
Mirtazapine—Body temperature increased—Docetaxel—head and neck cancer	0.000487	0.00132	CcSEcCtD
Mirtazapine—Hypersensitivity—Docetaxel—head and neck cancer	0.000454	0.00123	CcSEcCtD
Mirtazapine—Asthenia—Docetaxel—head and neck cancer	0.000442	0.0012	CcSEcCtD
Mirtazapine—Pruritus—Docetaxel—head and neck cancer	0.000436	0.00118	CcSEcCtD
Mirtazapine—ADRA2C—lymph node—head and neck cancer	0.000432	0.00525	CbGeAlD
Mirtazapine—Diarrhoea—Docetaxel—head and neck cancer	0.000422	0.00115	CcSEcCtD
Mirtazapine—HTR2A—head—head and neck cancer	0.000419	0.00508	CbGeAlD
Mirtazapine—Dizziness—Docetaxel—head and neck cancer	0.000407	0.00111	CcSEcCtD
Mirtazapine—Vomiting—Docetaxel—head and neck cancer	0.000392	0.00106	CcSEcCtD
Mirtazapine—Rash—Docetaxel—head and neck cancer	0.000388	0.00106	CcSEcCtD
Mirtazapine—Dermatitis—Docetaxel—head and neck cancer	0.000388	0.00105	CcSEcCtD
Mirtazapine—Headache—Docetaxel—head and neck cancer	0.000386	0.00105	CcSEcCtD
Mirtazapine—CYP2D6—head—head and neck cancer	0.000381	0.00463	CbGeAlD
Mirtazapine—Nausea—Docetaxel—head and neck cancer	0.000366	0.000994	CcSEcCtD
Mirtazapine—HRH1—lymph node—head and neck cancer	0.000351	0.00426	CbGeAlD
Mirtazapine—ADRA2A—lymph node—head and neck cancer	0.000345	0.00419	CbGeAlD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.24e-05	0.000155	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.23e-05	0.000155	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MAPK3—head and neck cancer	2.22e-05	0.000154	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.22e-05	0.000154	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—VEGFA—head and neck cancer	2.21e-05	0.000153	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.2e-05	0.000153	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	2.2e-05	0.000153	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	2.2e-05	0.000153	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTEN—head and neck cancer	2.19e-05	0.000152	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—PIK3CA—head and neck cancer	2.19e-05	0.000152	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—STAT3—head and neck cancer	2.19e-05	0.000152	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—HRAS—head and neck cancer	2.19e-05	0.000152	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	2.18e-05	0.000152	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MAPK3—head and neck cancer	2.18e-05	0.000151	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PTEN—head and neck cancer	2.17e-05	0.000151	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	2.15e-05	0.000149	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	2.15e-05	0.000149	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	2.15e-05	0.000149	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—HRAS—head and neck cancer	2.14e-05	0.000148	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—AKT1—head and neck cancer	2.13e-05	0.000148	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—AKT1—head and neck cancer	2.12e-05	0.000147	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MAPK1—head and neck cancer	2.11e-05	0.000146	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—EGFR—head and neck cancer	2.11e-05	0.000146	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	2.11e-05	0.000146	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	2.1e-05	0.000146	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL2—head and neck cancer	2.1e-05	0.000146	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	2.09e-05	0.000145	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MAPK3—head and neck cancer	2.09e-05	0.000145	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—STAT3—head and neck cancer	2.09e-05	0.000145	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	2.08e-05	0.000144	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—AKT1—head and neck cancer	2.08e-05	0.000144	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MAPK1—head and neck cancer	2.08e-05	0.000144	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—EGFR—head and neck cancer	2.08e-05	0.000144	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL2—head and neck cancer	2.06e-05	0.000143	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCND1—head and neck cancer	2.05e-05	0.000142	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	2.05e-05	0.000142	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	2.05e-05	0.000142	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—head and neck cancer	2.04e-05	0.000142	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	2.03e-05	0.000141	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—HRAS—head and neck cancer	2.02e-05	0.00014	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	2.02e-05	0.00014	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—TYMS—head and neck cancer	2.02e-05	0.00014	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL2—head and neck cancer	2.01e-05	0.00014	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCND1—head and neck cancer	2e-05	0.000139	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL2—head and neck cancer	2e-05	0.000139	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSTM1—head and neck cancer	2e-05	0.000139	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	1.99e-05	0.000138	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MAPK1—head and neck cancer	1.99e-05	0.000138	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EGFR—head and neck cancer	1.99e-05	0.000138	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	1.98e-05	0.000138	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PTEN—head and neck cancer	1.98e-05	0.000137	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—AKT1—head and neck cancer	1.97e-05	0.000137	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—VEGFA—head and neck cancer	1.96e-05	0.000136	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCND1—head and neck cancer	1.96e-05	0.000136	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.96e-05	0.000136	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.95e-05	0.000136	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCND1—head and neck cancer	1.95e-05	0.000135	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	1.95e-05	0.000135	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2—head and neck cancer	1.95e-05	0.000135	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—STAT3—head and neck cancer	1.94e-05	0.000135	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PTEN—head and neck cancer	1.94e-05	0.000134	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—AKT1—head and neck cancer	1.93e-05	0.000134	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GPX1—head and neck cancer	1.91e-05	0.000133	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	1.91e-05	0.000133	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCND1—head and neck cancer	1.9e-05	0.000132	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	1.9e-05	0.000132	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EGFR—head and neck cancer	1.9e-05	0.000132	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.89e-05	0.000131	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PTEN—head and neck cancer	1.89e-05	0.000131	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—AKT1—head and neck cancer	1.89e-05	0.000131	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PTEN—head and neck cancer	1.88e-05	0.000131	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MAPK3—head and neck cancer	1.86e-05	0.000129	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	1.85e-05	0.000128	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	1.84e-05	0.000127	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	1.84e-05	0.000127	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PTEN—head and neck cancer	1.83e-05	0.000127	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—PIK3CA—head and neck cancer	1.83e-05	0.000127	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.82e-05	0.000126	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	1.81e-05	0.000125	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	1.8e-05	0.000125	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—PIK3CA—head and neck cancer	1.8e-05	0.000125	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—head and neck cancer	1.79e-05	0.000124	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AKT1—head and neck cancer	1.79e-05	0.000124	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	1.78e-05	0.000124	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTEN—head and neck cancer	1.78e-05	0.000123	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.78e-05	0.000123	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—head and neck cancer	1.77e-05	0.000123	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STAT3—head and neck cancer	1.77e-05	0.000123	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	1.77e-05	0.000123	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—head and neck cancer	1.77e-05	0.000123	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MAPK1—head and neck cancer	1.77e-05	0.000123	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EGFR—head and neck cancer	1.76e-05	0.000123	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	1.76e-05	0.000122	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	1.75e-05	0.000122	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—head and neck cancer	1.75e-05	0.000121	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—head and neck cancer	1.74e-05	0.000121	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—head and neck cancer	1.74e-05	0.000121	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—head and neck cancer	1.73e-05	0.00012	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—head and neck cancer	1.73e-05	0.00012	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—head and neck cancer	1.72e-05	0.00012	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—head and neck cancer	1.72e-05	0.000119	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	1.72e-05	0.000119	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	1.71e-05	0.000119	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—head and neck cancer	1.7e-05	0.000118	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	1.7e-05	0.000118	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—head and neck cancer	1.69e-05	0.000118	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—head and neck cancer	1.69e-05	0.000118	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—head and neck cancer	1.69e-05	0.000117	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK3—head and neck cancer	1.69e-05	0.000117	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—head and neck cancer	1.69e-05	0.000117	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—head and neck cancer	1.68e-05	0.000117	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—head and neck cancer	1.67e-05	0.000116	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—head and neck cancer	1.67e-05	0.000116	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—head and neck cancer	1.66e-05	0.000115	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	1.66e-05	0.000115	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—head and neck cancer	1.65e-05	0.000115	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK3—head and neck cancer	1.65e-05	0.000115	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	1.65e-05	0.000114	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	1.64e-05	0.000114	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—head and neck cancer	1.64e-05	0.000114	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	1.63e-05	0.000113	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—head and neck cancer	1.63e-05	0.000113	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	1.62e-05	0.000113	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.62e-05	0.000112	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	1.62e-05	0.000112	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	1.61e-05	0.000112	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK1—head and neck cancer	1.61e-05	0.000112	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—head and neck cancer	1.61e-05	0.000112	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	1.6e-05	0.000111	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	1.6e-05	0.000111	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—head and neck cancer	1.6e-05	0.000111	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	1.59e-05	0.000111	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—head and neck cancer	1.59e-05	0.000111	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	1.59e-05	0.00011	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—head and neck cancer	1.58e-05	0.00011	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK1—head and neck cancer	1.57e-05	0.000109	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—head and neck cancer	1.57e-05	0.000109	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK3—head and neck cancer	1.56e-05	0.000109	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	1.56e-05	0.000108	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.56e-05	0.000108	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.56e-05	0.000108	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—head and neck cancer	1.54e-05	0.000107	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.54e-05	0.000107	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	1.54e-05	0.000107	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	1.54e-05	0.000107	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—head and neck cancer	1.54e-05	0.000107	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—head and neck cancer	1.53e-05	0.000106	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	1.53e-05	0.000106	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—head and neck cancer	1.53e-05	0.000106	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—head and neck cancer	1.52e-05	0.000106	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	1.5e-05	0.000104	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—head and neck cancer	1.49e-05	0.000104	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK1—head and neck cancer	1.49e-05	0.000103	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—head and neck cancer	1.49e-05	0.000103	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	1.49e-05	0.000103	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—head and neck cancer	1.49e-05	0.000103	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—head and neck cancer	1.48e-05	0.000103	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	1.48e-05	0.000103	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.48e-05	0.000102	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	1.47e-05	0.000102	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—head and neck cancer	1.47e-05	0.000102	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	1.46e-05	0.000101	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.46e-05	0.000101	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—head and neck cancer	1.46e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	1.45e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	1.45e-05	0.0001	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	1.43e-05	9.94e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	1.42e-05	9.85e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—head and neck cancer	1.42e-05	9.84e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—head and neck cancer	1.41e-05	9.8e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—head and neck cancer	1.41e-05	9.78e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	1.4e-05	9.7e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—head and neck cancer	1.4e-05	9.69e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	1.39e-05	9.68e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	1.37e-05	9.49e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—head and neck cancer	1.37e-05	9.48e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	1.35e-05	9.38e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—head and neck cancer	1.35e-05	9.37e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—head and neck cancer	1.35e-05	9.37e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—head and neck cancer	1.34e-05	9.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	1.34e-05	9.33e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	1.33e-05	9.27e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	1.33e-05	9.23e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	1.33e-05	9.23e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.33e-05	9.23e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	1.33e-05	9.22e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	1.33e-05	9.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	1.33e-05	9.21e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—head and neck cancer	1.33e-05	9.2e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—head and neck cancer	1.32e-05	9.17e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.32e-05	9.15e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	1.3e-05	9.03e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	1.3e-05	9.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—head and neck cancer	1.29e-05	8.97e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—head and neck cancer	1.29e-05	8.96e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—head and neck cancer	1.29e-05	8.96e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—head and neck cancer	1.28e-05	8.92e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	1.27e-05	8.82e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—head and neck cancer	1.26e-05	8.77e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—head and neck cancer	1.26e-05	8.76e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—head and neck cancer	1.25e-05	8.71e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—head and neck cancer	1.25e-05	8.69e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—head and neck cancer	1.25e-05	8.67e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—head and neck cancer	1.24e-05	8.57e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—head and neck cancer	1.23e-05	8.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	1.21e-05	8.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	1.21e-05	8.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—head and neck cancer	1.2e-05	8.3e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	1.17e-05	8.14e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.16e-05	8.05e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	1.15e-05	8.01e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	1.15e-05	7.99e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—head and neck cancer	1.15e-05	7.98e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—head and neck cancer	1.14e-05	7.91e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—head and neck cancer	1.13e-05	7.87e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	1.13e-05	7.84e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.13e-05	7.82e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—head and neck cancer	1.12e-05	7.74e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—head and neck cancer	1.12e-05	7.74e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—head and neck cancer	1.11e-05	7.73e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	1.09e-05	7.58e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—head and neck cancer	1.09e-05	7.57e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—head and neck cancer	1.08e-05	7.53e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—head and neck cancer	1.08e-05	7.53e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	1.07e-05	7.41e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—head and neck cancer	1.06e-05	7.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—head and neck cancer	1.06e-05	7.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	1.05e-05	7.28e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	1.04e-05	7.25e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—head and neck cancer	1.03e-05	7.12e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—head and neck cancer	1.01e-05	7.05e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	9.96e-06	6.91e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—head and neck cancer	9.82e-06	6.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	9.71e-06	6.74e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—head and neck cancer	9.57e-06	6.65e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	9.42e-06	6.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—head and neck cancer	9.4e-06	6.53e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	9.22e-06	6.4e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—head and neck cancer	8.69e-06	6.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	8.57e-06	5.95e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	8.18e-06	5.68e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—head and neck cancer	8.14e-06	5.65e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	8.11e-06	5.63e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—head and neck cancer	7.58e-06	5.26e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	6.93e-06	4.81e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—head and neck cancer	6.68e-06	4.64e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—head and neck cancer	6.62e-06	4.6e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—head and neck cancer	5.66e-06	3.93e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.35e-06	3.71e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—head and neck cancer	4.37e-06	3.03e-05	CbGpPWpGaD
